Financhill
Sell
9

FORR Quote, Financials, Valuation and Earnings

Last price:
$5.55
Seasonality move :
1.77%
Day range:
$5.79 - $6.25
52-week range:
$4.91 - $12.70
Dividend yield:
0%
P/E ratio:
239.75x
P/S ratio:
0.29x
P/B ratio:
0.74x
Volume:
316.6K
Avg. volume:
141.1K
1-year change:
-49.67%
Market cap:
$116.7M
Revenue:
$396.9M
EPS (TTM):
-$6.31

Analysts' Opinion

  • Consensus Rating
    Forrester Research, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $6.00, Forrester Research, Inc. has an estimated downside of -2.28% from its current price of $6.14.
  • Price Target Upside
    According to analysts, the highest upside price target is $6.00 representing -100% upside increase from its current price of $6.14.

Fair Value

  • According to the consensus of 2 analysts, Forrester Research, Inc. has -2.28% downside to fair value with a price target of $6.00 per share.

FORR vs. S&P 500

  • Over the past 5 trading days, Forrester Research, Inc. has underperformed the S&P 500 by -2.18% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Forrester Research, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Forrester Research, Inc. revenues have been falling on a year-over-year basis for 12 quarters in a row. In the most recent quarter Forrester Research, Inc. reported revenues of $101.1M.

Earnings Growth

  • Forrester Research, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Forrester Research, Inc. reported earnings per share of -$1.78.
Enterprise value:
59M
EV / Invested capital:
--
Price / LTM sales:
0.29x
EV / EBIT:
20.65x
EV / Revenue:
0.15x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
2.97x
Price / Operating cash flow:
5.94x
Enterprise value / EBITDA:
2.56x
Gross Profit (TTM):
$211.4M
Return On Assets:
-26.62%
Net Income Margin (TTM):
-30.07%
Return On Equity:
-45.8%
Return On Invested Capital:
-48.36%
Operating Margin:
-0.34%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $480.8M $432.5M $396.9M $108M $101.1M
Gross Profit $255.9M $232.7M $211.4M $59.8M $53.9M
Operating Income $20M $14.3M $2.9M $3.6M -$346K
EBITDA $52.1M $44.5M $23M $9.5M $3.1M
Diluted EPS $0.16 -$0.30 -$6.31 $0.02 -$1.78
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $239.9M $210.7M $192.8M $178.4M --
Total Assets $680.1M $608.4M $564.2M $503.9M --
Current Liabilities $312.3M $269.4M $240.1M $204M --
Total Liabilities $476.2M $386.8M $323.9M $274.3M --
Total Equity $203.9M $221.7M $240.3M $229.5M --
Total Debt $140M $100.8M $72.7M $59.8M $35M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $11.4M $9.9M $22.5M $264K $1.2M
Cash From Investing $5.2M -$38.3M -$15.5M $7.5M -$956K
Cash From Financing -$18.3M -$13.1M -$5.4M -$4.8M -$2.1M
Free Cash Flow $6.1M $5.5M $19.9M -$223K $524K
FORR
Sector
Market Cap
$116.7M
$477M
Price % of 52-Week High
48.35%
84.06%
Dividend Yield
0%
0%
Shareholder Yield
6.13%
1.69%
1-Year Price Total Return
-49.67%
--
Beta (5-Year)
0.931
0.541
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $6.09
200-day SMA
Sell
Level $8.99
Bollinger Bands (100)
Sell
Level 6.83 - 8.75
Chaikin Money Flow
Buy
Level 37.3M
20-day SMA
Sell
Level $7.04
Relative Strength Index (RSI14)
Sell
Level 33.40
ADX Line
Sell
Level 34.82
Williams %R
Neutral
Level -64.8571
50-day SMA
Sell
Level $7.44
MACD (12, 26)
Sell
Level -0.53
25-day Aroon Oscillator
Sell
Level -80
On Balance Volume
Neutral
Level 34.1M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.0144)
Sell
CA Score (Annual)
Level (-0.3026)
Buy
Beneish M-Score (Annual)
Level (-2.5494)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.3777)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Forrester Research, Inc. engages in the provision of advisory services. It operates through the following business segments: Research, Consulting, and Events. The Research segment includes the revenues of the research, connect, and analytics products. The Consulting segment consists of project consulting organization. The Events segment refers to developing and hosting in-person and virtual events. The firm serves the business-to-business marketing, sales, information technology, business-to-consumer marketing, and customer experience sectors. The company was founded by George F. Colony on July 7, 1983 and is headquartered in Cambridge, MA.

Stock Forecast FAQ

In the current month, FORR has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The FORR average analyst price target in the past 3 months is $6.00.

  • Where Will Forrester Research, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Forrester Research, Inc. share price will drop to $6.00 per share over the next 12 months.

  • What Do Analysts Say About Forrester Research, Inc.?

    Analysts are divided on their view about Forrester Research, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Forrester Research, Inc. is a Sell and believe this share price will rise from its current level to $6.00.

  • What Is Forrester Research, Inc.'s Price Target?

    The price target for Forrester Research, Inc. over the next 1-year time period is forecast to be $6.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is FORR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Forrester Research, Inc. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of FORR?

    You can purchase shares of Forrester Research, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Forrester Research, Inc. shares.

  • What Is The Forrester Research, Inc. Share Price Today?

    Forrester Research, Inc. was last trading at $5.55 per share. This represents the most recent stock quote for Forrester Research, Inc.. Yesterday, Forrester Research, Inc. closed at $6.14 per share.

  • How To Buy Forrester Research, Inc. Stock Online?

    In order to purchase Forrester Research, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 12.48% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 7.95% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock